No Data
No Data
China Development Corporation 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of China Development Corporation
Beihai Gofar Chuanshan Biological (600538.SH): Shareholder Peng Tao has completed the second public auction of 13.8 million shares of stocks.
On July 24th, Gelonhui reported that the Chengdu Qingyang District People's Court auctioned the 13.8 million shares of stock held by shareholder Peng Tao of Beihai Gofar Chuanshan Biological Company on the Taobao judicial auction platform from 3:00 pm on July 23, 2024 to 3:00 pm on July 24, 2024 for the second time. As of the disclosure date of this announcement, the above auction had ended in the online bidding stage, and Guo Huanzhen won the bidding online.
Beihai Gofar Chuanshan Biological (SHSE:600538 Shareholders Incur Further Losses as Stock Declines 22% This Week, Taking Three-year Losses to 55%
Announcement of expected loss in performance for the first half of 2024.
Beihai Gofar Chuanshan Biological (600538.SH): expects a pre-loss of about 16 million yuan in the first half of the year.
On July 9th, Gofar Chuanshan Biological (600538.SH) announced its performance forecast for the first half of 2024, expecting a net income attributable to the mother company's owner of about -16 million yuan. This represents an increase in losses compared to the same period last year. The net income attributable to the mother company's owner after deducting non-recurring gains and losses is expected to be about -17 million yuan for the first half of 2024.
No Data